Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co (SZSE:300937) Gross-Profit-to-Asset % : 22.24% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co's annualized Gross Profit for the quarter that ended in Mar. 2024 was ¥403 Mil. Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co's average Total Assets over the quarter that ended in Mar. 2024 was ¥1,813 Mil. Therefore, Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 22.24%.

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Gross-Profit-to-Asset % Chart

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

30.20

24.92

18.29

22.70

22.42

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															29.59	23.46	19.82	19.17	22.24

Competitive Comparison of Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co's Gross-Profit-to-Asset %

For the Pharmaceutical Retailers subindustry, Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co's Gross-Profit-to-Asset % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co's Gross-Profit-to-Asset % falls into.

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Gross-Profit-to-Asset % Calculation

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2023 )	/	( (Total Assets (A: Dec. 2022 )	+	Total Assets (A: Dec. 2023 ))	/ count )
	=	367.6	/	( (1591.618	+	1687.065)	/ 2 )
	=	367.6	/	1639.3415
	=	22.42 %

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	403.24	/	( (1687.065	+	1938.43)	/ 2 )
	=	403.24	/	1812.7475
	=	22.24 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co (SZSE:300937) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd (SZSE:300937) » Definitions » Gross-Profit-to-Asset %

Traded in Other Exchanges

N/A

Address

No. 18, Youlian 1st Street, 13th Floor, Jinniu District, Sichuan Province, Chengdu, CHN, 610081

Website

https://www.hezongyy.com

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd provides convenient, efficient and low-cost medical circulation services for the vast community medical terminals and primary medical institutions. It offers various products such as respiratory system, cardiovascular and neurological drugs, biological product, rheumatism and bone injuries and other medicines, cardiovascular and neurological drugs and others.

Executives

Tian Wen Shu	Supervisors
Ai Ying Ping	Director
Lei Qi Gang	Executives
Hao Rui Zhi	Directors, Directors, and Executives

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co (SZSE:300937) Headlines

No Headlines